Archive for September 2020

2 Releases in September and a Major Version upcoming in December !

Medexprim Suite™ is now bigger and better than ever before, with the simultaneous release of Radiomics Enabler® Version 1.4 and 1.5.
Under the hood, these two versions have exactly the same functionality.
Aditionally, v.1.5 updates Medexprim Suite™ to run on Docker, which makes installation and upgrade much easier. This new version can run on any operating system that supports Docker, including Windows 10.

Both versions include several important new features that our customers asked for:

  • an Audit Trail to record user logins and access to data.
  • an integrated Dicom Viewer to help validate correct de-identification of extracted Dicom images and Dicom SR files, prior to releasing data to a research project.
  • a significantly improved workflow making it possible to investigate and fix extraction errors, without viewing patient data and view the progress of a batch through the various processing stages. In particular, this allows Medexprim to effectively extend its support to client’s projects, in full respect of the regulations.
  • a clearer display of batch processing status, to show when a batch has completed de-identification and whether any files have been quarantined.
  • an extended API so that all batch related search, selection and extraction functions can be launched by external applications.

Version 2.0 is scheduled. It will feature an updated GUI and improvements to pipeline management. It will also be integrated with our new Indexa™ product, indexing the entire local PACS & RIS data in real time, aimed at accelerating searches & queries. More information here

Read More

European Commission’s Seal of Excellence

This summer, Medexprim received the European Commission’s Seal of Excellence for MIDAC (Medical Imaging Data Against Coronavirus), our project submitted to the EIC Accelerator COVID call. MIDAC’s goal was to constitute a centralized, collaborative and openly accessible Datalake of imaging exams and ancillary data with patients affected or not by Covid-19, and either release them to a qualified party for research, or help constitute synthetic control arms for existing clinical trials. This reinforces Medexprim’s position as a leader in the market of complex dataset creation & sourcing for clinical research, and encourages us to apply to the next “EIC Accelerator” call in October 2020, with a more ambitious project.

Together with leading EU university hospitals, with MIDAC, Medexprim’s mission was to facilitate the creation and enhancement of medical imaging databases and contextual data for research and for the development of new applications based on artificial intelligence.

Leveraging on this achievement, the Medexprim team is now applying the same approach to treatment against cancer and rare diseases. A great opportunity for our international partners to join our development dynamic !

Read More